|
Delayed
London S.E.
04:00:12 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 10.35 USD | +0.92% |
|
-0.20% | +25.26% |
| 08-20 | Will Moderna Wake Up the Health Care Sector? |  |
| 06-11 | IShares IV Public Limited Company Announces Interim Distribution for 2026, Payable on 30 June 2026 | CI |
Main features
| IE00BDZVHG35 | Fees | 0.35% | Dividend Policy | Distribution | |
|---|---|---|---|---|---|
| Currency | USD | AuM (CAD) | 122.45M | Replication Method | Direct (Physical) |
| Number of securities | 262 | AuM evolution | - | Date of creation | 2018-03-04 |
London S.E.USD
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| BTEE | Delayed | |
Tradegate
| OM3E | Real-time | |
Boerse Muenchen
| OM3E | Real-time | |
CBOE
| BTEE | Real-time |
| Name |
Indicative Price |
Change |
Weight | |
|---|---|---|---|---|
 | 159.08USD | +0.25% | 9.34% | |
| 521.03USD | +0.68% | 9.05% | |
| 447.95USD | +0.75% | 8.97% | |
| 816.10USD | +1.04% | 5.98% | |
| 226.79USD | -0.38% | 3.29% | |
| 94.96USD | +1.75% | 2.4% | |
| 252.73USD | +0.19% | 2.07% | |
| 882.48USD | +1.51% | 1.69% | |
| 591.20USD | -0.28% | 1.63% | |
| 207.97USD | +4.59% | 1.52% | |
Easily sort and filter through all available ETFs
Access the ETF ScreenerEconomic news
In partnership with
Investment objective
| Asset Classes | Stocks |
|---|---|
| Geographical Focus | United States |
| Theme and Sector | Biotechnology, Pharmaceuticals |
The iShares Nasdaq US Biotechnology UCITS ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ.
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-28 | US$10.35 | +0.92% | 34 |
| 26-10-27 | US$10.25 | +1.12% | 9,645 |
| 26-10-26 | US$10.14 | +0.06% | 46,566 |
| 26-10-23 | US$10.13 | -1.74% | 14,888 |
| 26-10-22 | US$10.31 | -0.54% | 37,407 |
- Stock Market
- ETF
- BTEE ETF
Select your edition
All financial news and data tailored to specific country editions
